Brain Trust Accelerator Fund
Impact investorBurlingame · Seed–Series A · 1 people tracked
Investment thesis
The Brain Trust Accelerator Funds concentrate on translational-stage investments targeting the diagnosis and treatment of brain-related diseases, framed as impact investing in brain disease. According to the page, its Fund I generated top-tier returns, supported approaches intended to benefit up to ten million patients with brain diseases, and delivered $500,000 to charities. The firm expresses similar optimism about the prospects for its Fund II.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2016 · 12010 · 12 dated
HealthtechBethesda, US
Michael E. Singer(Executive Officer, Director)Kerstin Schultz(Executive Officer)Laurie Silver(Executive Officer)
BoardJean Case(Director)Miles Gilburne(Director)
Board seatJohn M. Reher· per SEC Form D · $16.5M raise · filed Sep 2015
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)Greg N. Parekh(Director)John M. Siebert(Executive Officer, Director)
BoardNayan Greg Parekh(Director)
Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016
Co-investorsAndera Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Brain Trust Accelerator Fund invest at?
- Brain Trust Accelerator Fund invests at the Seed, Series A stages.
- What sectors does Brain Trust Accelerator Fund focus on?
- Brain Trust Accelerator Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Brain Trust Accelerator Fund located?
- Brain Trust Accelerator Fund is headquartered in Burlingame, US.
Similar investors
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.
Heran Partners invests in ventures improving and disrupting healthcare and life sciences through innovation and technology, seeking differentiated approaches built on solid IP and strong teams.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.